![Mark Street-Docherty](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Street-Docherty formerly worked at Delta Diagnostics (UK) Ltd., as Chief Executive Officer from 2017 to 2020 and Rosa Biotech Ltd., as Chief Executive Officer from 2022 to 2024.
| Unternehmen | Position | Ende |
|---|---|---|
Rosa Biotech Ltd.
 Rosa Biotech Ltd. Packaged SoftwareTechnology Services Operates as an AI-driven bio sensing and diagnostics company | Vorstandsvorsitzender | 01.01.2024 |
Delta Diagnostics (UK) Ltd.
 Delta Diagnostics (UK) Ltd. Miscellaneous Commercial ServicesCommercial Services Provides DNA diagnostics information | Vorstandsvorsitzender | 01.01.2020 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 2 |
|---|---|
Delta Diagnostics (UK) Ltd.
Delta Diagnostics (UK) Ltd. Miscellaneous Commercial ServicesCommercial Services Provides DNA diagnostics information | Commercial Services |
Rosa Biotech Ltd.
Rosa Biotech Ltd. Packaged SoftwareTechnology Services Operates as an AI-driven bio sensing and diagnostics company | Technology Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
